In Person Lecture: Tuning Stickiness and Charge of Nanomaterials to Target Cells and Tissues
Paula T. Hammond, Ph.D.
Professor and Department Head
Department of Chemical Engineering
Koch Institute of Integrative Cancer Research
Massachusetts Institute of Technology
Member, National Academy of Sciences, National Academy of Medicine, and National Academy of Engineering
Maury Strauss Distinguished Public Lecture: Tuning Stickiness and Charge of Nanomaterials to Target Cells and Tissues
Date: April 27, 2023
Time: 5:30 - 6:30 p.m. (Reception and hors d'oeuvres at 5 p.m.)
Location: Fralin Biomedical Research Institute at VTC, Room M203, 2 Riverside Circle, Roanoke, Virginia
Virtual attendance: Join via Zoom.
About this Seminar
Polyelectrolytes have unique properties that make them advantageous for the design of nanomaterials for drug delivery. These polymers are water-soluble, have a large number of easily modified reactive side chains for attachment of ligands, and can exhibit charge that can be designed to be sensitive to physiological conditions such as pH, redox conditions or the presence of specific enzymes. This capability makes charge a very enabling tool in the targeting of nanomaterials to specific tissues, as well as in adapting the transport of nanoparticles through typically charged and dense tissue matrices consisting largely of proteoglycans, polysaccharides or other biomolecular networks. In each case in which charge is an enabling factor for penetration in an oppositely charged matrix, there is also a complementary requirement to modulate the charge to enable interaction while affording effective diffusion and transport within tissues and organs. Examples include the use of charged polyamidoamine dendrimers for the penetration of drug into cartilage, and the use of polyethylene oxide shielding groups to modify the amount of charge exposed. Systematic studies reveal a critical parameter space within which we must balance these properties while maintaining biocompatibility of the nanocarrier, and a means of defining the effective charge in such shielded systems. Dr. Hammond and her lab have developed a modular nanoparticle approach using core particles and layering them with an electrostatic layer-by-layer (LBL) process in a simple and elegant method of constructing highly tailored ultrathin polymer coatings. The resulting LbL nanoparticles (LbL NPs) have negatively charged outer layers that present polyelectrolytes such as dextran sulfate or hyaluronic acid in a hydrated brush arrangement that enables hydration, steric repulsion, colloidal and serum stability, and specific or non-specific targeting. Ultimately, it is also important to introduce other kinds of interactions, particularly when targeting specific cells such as immune or cancer cells; often these interactions include receptor-specific interactions, but non-specific interactions can also have a very significant role in directing particles to cancer or other disease-associated cell types.
This is a free event hosted by Dr. Michael Friedlander and the Fralin Biomedical Research Institute. For more information, please call 540-526-2059.
About Maury Strauss
Maury Strauss is a longtime community benefactor and businessman who supports biomedical research with the goal of energizing the local economy and improving quality of life in our neighborhoods and around the world. In order to ensure the continued success of Roanoke’s biomedical research enterprise, as well as the free public seminars, Mr. Strauss has made a generous gift to the series. Read More.
Support Our Research
Your generous support of the Fralin Biomedical Research Institute's rigorous biomedical research enterprise makes a difference for our faculty, students, and patients. Every donation helps accelerate the pace of new discoveries to help patients with cancer, neurological disorders, heart disease, and even rare genetic disorders. Private donations fast-track our progress.
You May Also Be Interested In...
Home ItemCANCELLED: Virtual Seminar: Quantifying Diverse Research Representation , home
CANCELLED: March 31, 2023, 11:00 a.m. | Jonathan Jackson, Ph.D., Executive Director, Community Access, Recruitment, and Engagement (CARE) Research Center, Harvard University and Massachusetts General Hospital | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
Home ItemIn Person Lecture: Synaptic Injury: A Link to the Past , home
March 31, 2023, 1 p.m. | Terrance Kummer, M.D., Ph.D., Associate Professor of Neurology, Washington University School of Medicine in St. Louis | Timothy A. Johnson Medical Scholar Lecture Series
Home ItemSeminar: Understanding Cancer: From Development to Therapy , home
April 5, 2023, 11 a.m. | Biplab Dasgupta, M.S., Ph.D., MBA, Professor of Pediatrics, Division of Oncology, Cincinnati Children's Hospital | Seminar
Home ItemSeminar: Post-transcriptional Mechanisms of Survival in Quiescent Cancer Cells , home
April 13, 2023, 12 p.m. | Shobha Vasudevan, Ph.D., Associate Professor, Department of Medicine, Harvard Medical School | Seminar
Home ItemIn Person Seminar: Brain Dynamics and Flexible Behaviors , home
April 14, 2023, 11:00 am. | Lucina Q. Uddin, Ph.D., Professor in Residence, Department of Psychiatry and Biobehavioral Science, University of California, Los Angeles | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Addiction Recovery Research Center and Center for Health Behaviors Research
Home ItemIn Person Seminar: Engineering Post-translational Regulation of Ion Channels , home
April 21, 11 a.m. | Henry M. Colecraft, Ph.D., John C. Dalton Professor, Department of Physiology and Cellular Biophysics, Columbia University Irving Medical Center | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research